Companies Directory

Taiwan's largest cable company with over 1.1 million subscribers in 10 system operations. CNS provides more than 130 television channels in both analog and digital format, high speed internet access, and residential telephone service. In addition, CNS operates an internet service provider business and commercial high capacity network services through its subsidiary, KBT.

China Now is a private equity firm dedicated to empower global small to medium retail brands to achieve sustainable growth in China. We play a vital role in helping companies realize their growth potential in China through our three business sectors: Strategic Consulting, Brand Management, and Private Equity Investment.

CHINA PETROCHEMICAL DEVELOPMENT CORPORATION is a chemicals company based out of 8-11F, 12, Tung Hsing Rd.,, Taipei City, Taiwan.

CPPE-AD is a branch of China Petroleum Pipeline Engineering Corporation (CPPE) which was officially registered in Abu Dhabi on 25th December 2011. It is the first design consulting company that CNPC (China National Petroleum Corporation) established in Abu Dhabi. This branch was created according to CPPE's international strategy. Its main tasks include providing coordination for CPP (China Petroleum Pipeline Bureau) to complete its design tasks in Middle East and more importantly, strengthening strategic cooperation with other Western famous companies, with the purpose of developing the international high-end market, further improving CPPE's brand popularity and laying solid foundations for CPPE to occupy the international market in the future. The branch is mainly engaged in onshore and offshore oil field service, oil/gas pipeline and tank design consulting service, mechanical and power engineering design consulting, water engineering design, oil/gas field facility consulting, construction project management, and measurement and survey engineering consulting. CPPE, a large state-owned enterprise based on the former CNPC (China National Petroleum Corporation) Pipeline Survey and Design Institute, is an engineering company holding qualification certificates inclusive of Engineering Design (Class A, Integrated) and Engineering Survey (Class A, Integrated) issued by the related State authorities and mainly provides services of consultation, survey, design, research of storage and transportation technology, project management, supervision as well as EPC for long distance transportation pipeline projects, oil and gas field surface construction, large scale oil and gas storage facilities, near-shore oil and gas field development, terminals of offshore oil and gas development, public building works, municipal projects, etc., in home and abroad.

China Prosperity Capital Fund (“CPC Fund”), jointly founded by Mr. Hendrick Sin, Mr. Xiao Jian and Mr. Ma Zhijiang in 2015, is a private equity fund focusing on investments in mobile internet, in particular the pan entertainment sector, in Greater China. Mr. Sin and Mr. Xiao are co-founders of CMGE Group Limited, the largest publisher of mobile games in China and a company listed on the NASDAQ market in United States from September 2012 to August 2015. CMGE was China’s first mobile game company listed in an overseas stock exchange. “Enhancing business efficiency, connecting with capital markets” was the mission laid down by the founding partners at the time CPC Fund was established. CPC Fund is determined to become a uniquely positioned world-class private equity firm. CPC Fund partners with the management teams of its portfolio companies to continuously enhance their value and operations models by providing them with operational enhancement services based on CPC Fund’s rich industry and sector knowledge as well as business connections, and an unique understanding of capital markets. CPC Fund believes that this approach is the best way to enhance value for its investments and achieve the desired superior returns for its investors.

China Regenerative Medicine International Limited ("CRMI") is principally engaged in R&D, production and distribution of bio-medical and healthcare products, consists of : 1) Cellular Therapy China Stem Cell Clinical Application Centre is currently built in Hong Kong, which complies with the highest standards set forth by EMA, US FDA and CFDA, set to be the world's leading GMP centre specializing in stem cell clinical applications and gene therapy, and a regional supply centre of cellular products for research, development and clinical purposes. Smaller scale but similar graded GMP cell processing facilities are operating in Suzhou, and will be serving in Tianjin, Shenzhen and others in the future. Inside those, we also provide adult tissue storage service for unmet medical needs. 2) Tissue Engineering Bio-Medical Devices We own three manufacturing plants in Xian and Shenzhen and successfully develop and launch : a) the world's unique acellular corneal stroma (Acornea) for laminar keratoplasty that can help corneal blindness patient restoring their vision b) tissue engineering skin (ActivSkin) which contain human live cell for burn skin and ulcer recovery c) Calcined Bovine Bone (CBB) which is bone generative powder for dental implantation and to treat periodontal defects d) Acellular Small Intestinal Submucosa (Resunin), which is for the repair of soft tissue in fistula to maintains the function of the anal sphincter e) Autologous Chondrocyte Implantation - Cell Sheet, which is the fourth generation technique to grow knee cartilage into cell sheet for reconstruction of knee function without prosthesis application. 3) Cosmetics & Healthcare Products Utilizing cell growth factors derived from TE process to develop avant-grade cosmetics & skincare products 4) Medical Equipment & Other Services 3D perfusion cell culture technology used in pre-clinical drug efficacy and toxicity testing and 3D perfusion bioreactors were developed and launched

China Regenerative Medicine International Limited ("CRMI") is principally engaged in R&D, production and distribution of bio-medical and healthcare products, consists of : 1) Cellular Therapy China Stem Cell Clinical Application Centre is currently built in Hong Kong, which complies with the highest standards set forth by EMA, US FDA and CFDA, set to be the world's leading GMP centre specializing in stem cell clinical applications and gene therapy, and a regional supply centre of cellular products for research, development and clinical purposes. Smaller scale but similar graded GMP cell processing facilities are operating in Suzhou, and will be serving in Tianjin, Shenzhen and others in the future. Inside those, we also provide adult tissue storage service for unmet medical needs. 2) Tissue Engineering Bio-Medical Devices We own three manufacturing plants in Xian and Shenzhen and successfully develop and launch : a) the world's unique acellular corneal stroma (Acornea) for laminar keratoplasty that can help corneal blindness patient restoring their vision b) tissue engineering skin (ActivSkin) which contain human live cell for burn skin and ulcer recovery c) Calcined Bovine Bone (CBB) which is bone generative powder for dental implantation and to treat periodontal defects d) Acellular Small Intestinal Submucosa (Resunin), which is for the repair of soft tissue in fistula to maintains the function of the anal sphincter e) Autologous Chondrocyte Implantation - Cell Sheet, which is the fourth generation technique to grow knee cartilage into cell sheet for reconstruction of knee function without prosthesis application. 3) Cosmetics & Healthcare Products Utilizing cell growth factors derived from TE process to develop avant-grade cosmetics & skincare products 4) Medical Equipment & Other Services 3D perfusion cell culture technology used in pre-clinical drug efficacy and toxicity testing and 3D perfusion bioreactors were developed and launched

China Resources Vanguard Co., Ltd. is a supermarkets company based out of Shuibei 2nd Rd, Shenzhen, Guangdong, China.

China Securities (International) Finance Holding Company Limited (中信建投(國際)金融控股有限公司) ("CSCI" or the "Company") is a wholly-owned subsidiary of China Securities Co., Ltd. ("CSC") , one of the leading nationwide full-service securities company in China. CSC was listed on the main board of Hong Kong Stock Exchange (Stock Code: 6066.HK) and list on the main board of the Shanghai Stock Exchange (Stock Code: 601066.SH). It enjoys strong shareholders supports including Beijing State-owned Capital Operation and Management Center, Central Huijin Investment Limited and CITIC Limited which are large enterprises possessed of strong capital support, sophisticated capital operations experience and relatively high renowned reputation. CSCI was established in Hong Kong on July 2012, the Company is committed to becoming an innovative and pioneeringinvestment bank. In order to better serve our corporate, institutional and wealth management clients, we provide a wide range of products and services, leveraging throughour Corporate Finance, Asset Management, Securities & Futures Trading, Equity Research, Institutional Sales, FICCand Structured Financing and other businesses. As CSC’s flagship entity to enter into the international capital market, CSCI is home to a team of young, enthusiastic and savvy professionals and management caliber with extensive experience in corporate finance, asset management and brokerage,which secures the company’s sustainable long-term development.